Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,295
Total Claims
$1.3M
Drug Cost
1,035
Beneficiaries
$1,262
Cost/Patient
Risk Score Breakdown 38/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+95%
Opioid rate vs peers
67.7% vs 34.8% avg
+199%
Cost per patient vs peers
$1,262 vs $422 avg
+178%
Brand preference vs peers
13.2% vs 4.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
67.7%
Opioid Rate
6,973
Opioid Claims
$1.0M
Opioid Cost
31.8%
Long-Acting Rate
This provider's opioid prescribing rate of 67.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,356 claims · $639K
Generic: 8,939 claims · $667K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine | 1,121 | $396K |
| Buprenorphine Hcl | 200 | $165K |
| Oxycodone Hcl | 154 | $119K |
| Buprenorphine | 144 | $116K |
| Hydrocodone/Acetaminophen | 1,748 | $68K |
| Oxycodone Hcl/Acetaminophen | 789 | $44K |
| Ubrogepant | 15 | $39K |
| Buprenorphine Hcl | 602 | $34K |
| Oxycodone Hcl | 947 | $26K |
| Buprenorphine Hcl/Naloxone Hcl | 111 | $23K |
| Naloxegol Oxalate | 39 | $22K |
| Fentanyl | 138 | $19K |
| Pregabalin | 326 | $16K |
| Hydromorphone Hcl | 723 | $12K |
| Oxycodone Myristate | 17 | $12K |
Prescribing Profile
56
Unique Drugs
38.0
Anomaly Score
Patient Profile
71
Avg Age
68%
Female
1.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About